tiprankstipranks
Advertisement
Advertisement
Novo Nordisk Completes Key CagriSema vs. Tirzepatide Diabetes Trial: What Investors Should Watch
PremiumCompany AnnouncementsNovo Nordisk Completes Key CagriSema vs. Tirzepatide Diabetes Trial: What Investors Should Watch
1d ago
Dr. Reddy’s awaiting approval for Semaglutide in Canada, CNBC-TV18 says
Premium
The Fly
Dr. Reddy’s awaiting approval for Semaglutide in Canada, CNBC-TV18 says
1d ago
Novo Nordisk announces positive top-line results from Pioneer Teens study
Premium
The Fly
Novo Nordisk announces positive top-line results from Pioneer Teens study
1d ago
Lilly, Novo slip after CVS opts out of Medicare obesity drug model
PremiumThe FlyLilly, Novo slip after CVS opts out of Medicare obesity drug model
3d ago
UnitedHealth sees ‘challenges’ with current Medicare weight loss drug plans
Premium
The Fly
UnitedHealth sees ‘challenges’ with current Medicare weight loss drug plans
3d ago
Agios Pharmaceuticals price target lowered to $41 from $44 at BofA
Premium
The Fly
Agios Pharmaceuticals price target lowered to $41 from $44 at BofA
3d ago
Novo Nordisk reports Etavopivat met co-primary endpoints in HIBISCUS trial
PremiumThe FlyNovo Nordisk reports Etavopivat met co-primary endpoints in HIBISCUS trial
4d ago
Agios sinks after Novo Nordisk reports sickle cell data
Premium
The Fly
Agios sinks after Novo Nordisk reports sickle cell data
4d ago
Agios could come under pressure off Novo Nordisk headline, says Truist
Premium
The Fly
Agios could come under pressure off Novo Nordisk headline, says Truist
4d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100